| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enhancer Elements, Genetic | 18 | 2024 | 284 | 5.350 |
Why?
|
| Gene Expression Regulation, Developmental | 23 | 2024 | 667 | 4.850 |
Why?
|
| Multigene Family | 10 | 2018 | 202 | 2.430 |
Why?
|
| Genes, Homeobox | 8 | 2013 | 83 | 2.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 9 | 2015 | 156 | 1.650 |
Why?
|
| Embryonic Development | 4 | 2020 | 79 | 1.390 |
Why?
|
| Mice | 38 | 2024 | 11949 | 1.360 |
Why?
|
| Homeodomain Proteins | 11 | 2015 | 558 | 1.330 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 1991 | 1.310 |
Why?
|
| Mice, Transgenic | 15 | 2016 | 1583 | 1.170 |
Why?
|
| Promoter Regions, Genetic | 15 | 2016 | 961 | 1.120 |
Why?
|
| Transcription, Genetic | 6 | 2024 | 1161 | 1.100 |
Why?
|
| Genome | 6 | 2018 | 393 | 1.040 |
Why?
|
| Animals | 48 | 2024 | 27715 | 1.030 |
Why?
|
| Embryo, Mammalian | 7 | 2024 | 223 | 0.920 |
Why?
|
| Chromatin | 5 | 2018 | 408 | 0.860 |
Why?
|
| Evolution, Molecular | 8 | 2016 | 857 | 0.820 |
Why?
|
| F-Box Proteins | 2 | 2013 | 13 | 0.730 |
Why?
|
| Hedgehog Proteins | 3 | 2016 | 100 | 0.700 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 60 | 0.670 |
Why?
|
| Lentivirus | 2 | 2010 | 43 | 0.660 |
Why?
|
| Gene Regulatory Networks | 5 | 2016 | 309 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2024 | 130 | 0.650 |
Why?
|
| Transcription Factors | 8 | 2019 | 1670 | 0.630 |
Why?
|
| Receptors, Odorant | 1 | 2019 | 39 | 0.610 |
Why?
|
| Odorants | 1 | 2019 | 71 | 0.610 |
Why?
|
| Sea Anemones | 1 | 2018 | 16 | 0.610 |
Why?
|
| Extremities | 2 | 2011 | 176 | 0.600 |
Why?
|
| Genes, myc | 1 | 2018 | 40 | 0.590 |
Why?
|
| Chromosome Positioning | 1 | 2017 | 3 | 0.590 |
Why?
|
| DNA-Binding Proteins | 4 | 2019 | 1247 | 0.590 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 399 | 0.570 |
Why?
|
| DNA Transposable Elements | 3 | 2015 | 175 | 0.560 |
Why?
|
| Limb Deformities, Congenital | 2 | 2008 | 19 | 0.530 |
Why?
|
| Chordata | 1 | 2016 | 10 | 0.520 |
Why?
|
| Disease | 2 | 2016 | 90 | 0.520 |
Why?
|
| Gene Order | 2 | 2013 | 23 | 0.510 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 309 | 0.510 |
Why?
|
| Prosencephalon | 1 | 2016 | 64 | 0.500 |
Why?
|
| Leukemia | 1 | 2018 | 320 | 0.500 |
Why?
|
| Chromosome Duplication | 1 | 2015 | 8 | 0.500 |
Why?
|
| Transcription Factor AP-2 | 1 | 2015 | 14 | 0.490 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2015 | 13 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2015 | 66 | 0.490 |
Why?
|
| Cleft Lip | 1 | 2014 | 15 | 0.460 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 295 | 0.460 |
Why?
|
| Cleft Palate | 1 | 2014 | 26 | 0.460 |
Why?
|
| RNA | 1 | 2018 | 588 | 0.450 |
Why?
|
| Morphogenesis | 2 | 2020 | 207 | 0.450 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 204 | 0.450 |
Why?
|
| Genetic Loci | 1 | 2015 | 253 | 0.440 |
Why?
|
| Genes, Switch | 1 | 2013 | 8 | 0.440 |
Why?
|
| Genetic Vectors | 2 | 2008 | 446 | 0.440 |
Why?
|
| Face | 1 | 2014 | 118 | 0.430 |
Why?
|
| Binding Sites | 3 | 2014 | 1127 | 0.430 |
Why?
|
| Forelimb | 1 | 2013 | 19 | 0.430 |
Why?
|
| Genomic Structural Variation | 1 | 2013 | 8 | 0.420 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2013 | 28 | 0.420 |
Why?
|
| Trans-Activators | 4 | 2004 | 443 | 0.400 |
Why?
|
| Muscle Proteins | 1 | 2013 | 132 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 7 | 2020 | 3278 | 0.390 |
Why?
|
| Embryonic Stem Cells | 2 | 2024 | 82 | 0.390 |
Why?
|
| Databases, Genetic | 1 | 2013 | 270 | 0.380 |
Why?
|
| Chromosomes, Mammalian | 3 | 2013 | 36 | 0.380 |
Why?
|
| Heart | 1 | 2015 | 580 | 0.380 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 294 | 0.370 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2010 | 177 | 0.370 |
Why?
|
| Genetic Techniques | 1 | 2011 | 73 | 0.360 |
Why?
|
| Repressor Proteins | 2 | 2014 | 428 | 0.350 |
Why?
|
| Genes, Intracisternal A-Particle | 1 | 2010 | 3 | 0.350 |
Why?
|
| Chromosomes | 3 | 2019 | 99 | 0.340 |
Why?
|
| In Situ Hybridization | 4 | 2014 | 313 | 0.340 |
Why?
|
| Endogenous Retroviruses | 1 | 2010 | 10 | 0.340 |
Why?
|
| Nuclear Proteins | 4 | 2010 | 728 | 0.330 |
Why?
|
| Muscle, Skeletal | 3 | 2013 | 473 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 3 | 2010 | 511 | 0.330 |
Why?
|
| Neurons | 1 | 2018 | 1593 | 0.330 |
Why?
|
| Developmental Biology | 2 | 2006 | 29 | 0.330 |
Why?
|
| Gene Silencing | 1 | 2010 | 178 | 0.320 |
Why?
|
| Virus Integration | 1 | 2008 | 17 | 0.300 |
Why?
|
| Obesity | 1 | 2015 | 979 | 0.300 |
Why?
|
| Genomics | 3 | 2018 | 784 | 0.300 |
Why?
|
| Retroelements | 1 | 2008 | 49 | 0.300 |
Why?
|
| Genes, Reporter | 6 | 2011 | 274 | 0.290 |
Why?
|
| Tretinoin | 3 | 2020 | 130 | 0.290 |
Why?
|
| Mutagenesis, Insertional | 1 | 2008 | 114 | 0.290 |
Why?
|
| Vertebrates | 1 | 2008 | 105 | 0.270 |
Why?
|
| Humans | 28 | 2024 | 90640 | 0.260 |
Why?
|
| Chromosome Mapping | 4 | 2013 | 1074 | 0.260 |
Why?
|
| Gene Duplication | 3 | 2016 | 129 | 0.250 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 47 | 0.250 |
Why?
|
| Transgenes | 5 | 2013 | 185 | 0.250 |
Why?
|
| Fructose-Bisphosphate Aldolase | 3 | 2004 | 11 | 0.240 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2004 | 4 | 0.240 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2004 | 4 | 0.240 |
Why?
|
| Germ Cells | 1 | 2005 | 130 | 0.230 |
Why?
|
| Chickens | 3 | 2013 | 212 | 0.230 |
Why?
|
| Oncogenes | 1 | 2024 | 97 | 0.230 |
Why?
|
| Pluripotent Stem Cells | 1 | 2024 | 35 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 4 | 2010 | 872 | 0.220 |
Why?
|
| Sequence Deletion | 2 | 2018 | 205 | 0.220 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 16 | 0.220 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2010 | 30 | 0.220 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 184 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2034 | 0.210 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 285 | 0.200 |
Why?
|
| Bone Diseases, Developmental | 1 | 2002 | 11 | 0.200 |
Why?
|
| Colorectal Neoplasms | 2 | 2001 | 974 | 0.200 |
Why?
|
| Models, Genetic | 3 | 2016 | 952 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 888 | 0.190 |
Why?
|
| Spine | 1 | 2002 | 102 | 0.190 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 264 | 0.180 |
Why?
|
| Lac Operon | 2 | 2011 | 47 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2015 | 2409 | 0.180 |
Why?
|
| Oculomotor Muscles | 1 | 2020 | 29 | 0.180 |
Why?
|
| DNA, Complementary | 1 | 2001 | 391 | 0.180 |
Why?
|
| Gene Deletion | 2 | 2018 | 345 | 0.180 |
Why?
|
| Interferon-beta | 1 | 2001 | 126 | 0.180 |
Why?
|
| Female | 16 | 2024 | 46894 | 0.170 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 538 | 0.170 |
Why?
|
| Base Sequence | 4 | 2008 | 2329 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2001 | 349 | 0.170 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2013 | 101 | 0.170 |
Why?
|
| Biological Evolution | 1 | 2008 | 984 | 0.170 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 118 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 742 | 0.160 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2019 | 21 | 0.160 |
Why?
|
| Myogenin | 1 | 1998 | 5 | 0.160 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2019 | 16 | 0.160 |
Why?
|
| LIM Domain Proteins | 1 | 2019 | 25 | 0.160 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 72 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 1286 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 1999 | 122 | 0.160 |
Why?
|
| Genetic Therapy | 1 | 2001 | 373 | 0.150 |
Why?
|
| Male | 13 | 2024 | 42967 | 0.150 |
Why?
|
| Phenotype | 4 | 2016 | 2473 | 0.150 |
Why?
|
| Tubulin | 1 | 2018 | 60 | 0.150 |
Why?
|
| Phylogeny | 2 | 2018 | 1219 | 0.150 |
Why?
|
| Central Nervous System | 2 | 2010 | 154 | 0.150 |
Why?
|
| Multipotent Stem Cells | 1 | 2018 | 19 | 0.150 |
Why?
|
| Smell | 1 | 2019 | 113 | 0.150 |
Why?
|
| Myeloid Cells | 1 | 2018 | 103 | 0.140 |
Why?
|
| Cluster Analysis | 1 | 2018 | 372 | 0.140 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 64 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 3030 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 243 | 0.130 |
Why?
|
| Cell Lineage | 1 | 2018 | 296 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 78 | 0.130 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 163 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2018 | 521 | 0.130 |
Why?
|
| Liver | 2 | 2017 | 1218 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 180 | 0.120 |
Why?
|
| Mutation | 2 | 2004 | 4183 | 0.120 |
Why?
|
| Blastocyst | 1 | 2015 | 35 | 0.120 |
Why?
|
| Branchial Region | 1 | 2015 | 16 | 0.120 |
Why?
|
| Actins | 1 | 2018 | 469 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2001 | 760 | 0.120 |
Why?
|
| Syndrome | 1 | 2015 | 452 | 0.110 |
Why?
|
| Amino Acid Sequence | 3 | 2004 | 2077 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2018 | 1500 | 0.110 |
Why?
|
| CCCTC-Binding Factor | 1 | 2014 | 18 | 0.110 |
Why?
|
| Limb Buds | 2 | 2004 | 7 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 1182 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 137 | 0.110 |
Why?
|
| Oryzias | 1 | 2013 | 5 | 0.110 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 135 | 0.110 |
Why?
|
| Integrases | 1 | 2013 | 63 | 0.110 |
Why?
|
| Lymphatic Metastasis | 3 | 2000 | 498 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 526 | 0.110 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 741 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2013 | 309 | 0.100 |
Why?
|
| Transcriptome | 1 | 2018 | 674 | 0.100 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2005 | 355 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 115 | 0.100 |
Why?
|
| Epistasis, Genetic | 1 | 2013 | 90 | 0.100 |
Why?
|
| Telomere | 1 | 2013 | 119 | 0.100 |
Why?
|
| Alleles | 2 | 2008 | 1138 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1462 | 0.100 |
Why?
|
| Gene Dosage | 1 | 2013 | 210 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2013 | 279 | 0.100 |
Why?
|
| User-Computer Interface | 1 | 2013 | 187 | 0.100 |
Why?
|
| Xenopus | 1 | 2011 | 126 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2016 | 766 | 0.090 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 802 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2018 | 1553 | 0.090 |
Why?
|
| Transposases | 1 | 2011 | 23 | 0.090 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2010 | 5 | 0.090 |
Why?
|
| Mice, Inbred DBA | 2 | 2020 | 150 | 0.090 |
Why?
|
| Cell Nucleus | 3 | 2004 | 605 | 0.090 |
Why?
|
| Prognosis | 2 | 2018 | 3813 | 0.090 |
Why?
|
| Internet | 1 | 2013 | 324 | 0.090 |
Why?
|
| Conserved Sequence | 2 | 2003 | 211 | 0.090 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2010 | 1 | 0.090 |
Why?
|
| Leukemia Virus, Murine | 1 | 2010 | 18 | 0.090 |
Why?
|
| 5' Untranslated Regions | 1 | 2010 | 52 | 0.080 |
Why?
|
| Gestational Age | 1 | 2011 | 327 | 0.080 |
Why?
|
| Acetylation | 1 | 2010 | 141 | 0.080 |
Why?
|
| Peritoneal Neoplasms | 2 | 2001 | 181 | 0.080 |
Why?
|
| Computational Biology | 1 | 2013 | 552 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2020 | 3431 | 0.080 |
Why?
|
| Centromere | 1 | 2009 | 26 | 0.080 |
Why?
|
| Neoplasms | 1 | 2024 | 3030 | 0.080 |
Why?
|
| Sarcoma | 2 | 2001 | 217 | 0.080 |
Why?
|
| Methylation | 1 | 2010 | 276 | 0.080 |
Why?
|
| Eukaryotic Cells | 1 | 2008 | 44 | 0.080 |
Why?
|
| Proviruses | 1 | 2008 | 15 | 0.080 |
Why?
|
| Wills | 1 | 2008 | 5 | 0.080 |
Why?
|
| Lysine | 1 | 2010 | 179 | 0.080 |
Why?
|
| Gene Transfer Techniques | 2 | 2013 | 153 | 0.080 |
Why?
|
| Genes, Developmental | 1 | 2008 | 6 | 0.070 |
Why?
|
| Mosaicism | 1 | 2008 | 71 | 0.070 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1695 | 0.070 |
Why?
|
| Histones | 1 | 2010 | 344 | 0.070 |
Why?
|
| Body Patterning | 1 | 2009 | 216 | 0.070 |
Why?
|
| Lymph Nodes | 3 | 2000 | 553 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2004 | 46 | 0.070 |
Why?
|
| Plasmids | 1 | 2007 | 292 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2013 | 1384 | 0.070 |
Why?
|
| Rats | 1 | 2012 | 4061 | 0.060 |
Why?
|
| Skin Physiological Phenomena | 1 | 2006 | 27 | 0.060 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 171 | 0.060 |
Why?
|
| Melanoma | 2 | 2000 | 474 | 0.060 |
Why?
|
| Species Specificity | 1 | 2007 | 690 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 2364 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2010 | 666 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 388 | 0.060 |
Why?
|
| X Chromosome | 1 | 2005 | 153 | 0.060 |
Why?
|
| Fetal Proteins | 1 | 2004 | 17 | 0.060 |
Why?
|
| Dihematoporphyrin Ether | 2 | 2001 | 4 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2000 | 601 | 0.060 |
Why?
|
| Mesoderm | 1 | 2004 | 124 | 0.060 |
Why?
|
| Pregnancy | 1 | 2011 | 3070 | 0.050 |
Why?
|
| Takifugu | 1 | 2003 | 4 | 0.050 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 35 | 0.050 |
Why?
|
| Genitalia | 1 | 2003 | 21 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 281 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2003 | 173 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 120 | 0.050 |
Why?
|
| Protein Binding | 2 | 2004 | 1500 | 0.050 |
Why?
|
| Tacrolimus | 1 | 2004 | 371 | 0.050 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 231 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2004 | 211 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2004 | 158 | 0.050 |
Why?
|
| Cell Line | 2 | 2015 | 2505 | 0.050 |
Why?
|
| Genotype | 1 | 2007 | 1855 | 0.050 |
Why?
|
| Hindlimb | 1 | 2002 | 96 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 85 | 0.050 |
Why?
|
| Muscles | 1 | 2002 | 192 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 83 | 0.050 |
Why?
|
| Genes, Synthetic | 1 | 2001 | 7 | 0.050 |
Why?
|
| Leg | 1 | 2002 | 140 | 0.050 |
Why?
|
| Arm | 1 | 2002 | 99 | 0.050 |
Why?
|
| Bone Development | 1 | 2001 | 37 | 0.050 |
Why?
|
| Hematoporphyrin Photoradiation | 1 | 2001 | 1 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2001 | 101 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 2328 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 238 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2001 | 82 | 0.050 |
Why?
|
| Survival Rate | 3 | 2001 | 1895 | 0.050 |
Why?
|
| Connective Tissue | 1 | 2020 | 23 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2000 | 11 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2000 | 16 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2001 | 260 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2002 | 151 | 0.040 |
Why?
|
| Models, Biological | 1 | 2008 | 1770 | 0.040 |
Why?
|
| Tendons | 1 | 2020 | 45 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2001 | 397 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2001 | 125 | 0.040 |
Why?
|
| Cytokines | 1 | 2004 | 814 | 0.040 |
Why?
|
| Photochemotherapy | 1 | 2001 | 100 | 0.040 |
Why?
|
| Eye | 1 | 2020 | 111 | 0.040 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1999 | 3 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2001 | 491 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2001 | 277 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 1049 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 565 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2001 | 819 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 446 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 41 | 0.040 |
Why?
|
| DNA | 2 | 2016 | 1314 | 0.040 |
Why?
|
| Keratins | 1 | 1999 | 63 | 0.040 |
Why?
|
| Response Elements | 1 | 1999 | 65 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 354 | 0.040 |
Why?
|
| Fetal Heart | 1 | 1998 | 13 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 72 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 1095 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1998 | 125 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2001 | 2337 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 284 | 0.040 |
Why?
|
| Macrophages | 1 | 2001 | 585 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1998 | 291 | 0.040 |
Why?
|
| Spleen | 1 | 1998 | 433 | 0.040 |
Why?
|
| Carcinoma | 1 | 2001 | 438 | 0.040 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1998 | 478 | 0.030 |
Why?
|
| Fluorouracil | 1 | 1998 | 548 | 0.030 |
Why?
|
| Foot Deformities, Congenital | 1 | 2016 | 10 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 2016 | 15 | 0.030 |
Why?
|
| Transfection | 1 | 1998 | 910 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 27 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Up-Regulation | 1 | 1999 | 728 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 602 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2003 | 1232 | 0.030 |
Why?
|
| Fingers | 1 | 2016 | 69 | 0.030 |
Why?
|
| Algorithms | 1 | 2024 | 1919 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 574 | 0.030 |
Why?
|
| Myeloid Ecotropic Viral Integration Site 1 Protein | 1 | 2015 | 20 | 0.030 |
Why?
|
| Radionuclide Imaging | 3 | 2000 | 222 | 0.030 |
Why?
|
| Apoptosis | 1 | 2001 | 1725 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 1999 | 2895 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2013 | 183 | 0.030 |
Why?
|
| Time Factors | 1 | 2001 | 5366 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 1313 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 1362 | 0.020 |
Why?
|
| Biopsy | 3 | 2000 | 1192 | 0.020 |
Why?
|
| Zebrafish | 1 | 2013 | 323 | 0.020 |
Why?
|
| Lymph Node Excision | 2 | 2000 | 222 | 0.020 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 1709 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 3020 | 0.020 |
Why?
|
| Middle Aged | 5 | 2001 | 26347 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 3698 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 2002 | 29 | 0.010 |
Why?
|
| Pennsylvania | 1 | 2001 | 96 | 0.010 |
Why?
|
| Laparotomy | 1 | 2001 | 68 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2000 | 66 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2000 | 56 | 0.010 |
Why?
|
| Adult | 4 | 2001 | 26953 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2000 | 123 | 0.010 |
Why?
|
| Cytosol | 1 | 2000 | 193 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 419 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2000 | 324 | 0.010 |
Why?
|
| Technetium Tc 99m Sulfur Colloid | 1 | 1999 | 11 | 0.010 |
Why?
|
| Rosaniline Dyes | 1 | 1999 | 11 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 263 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 520 | 0.010 |
Why?
|
| Protein Transport | 1 | 2000 | 426 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2001 | 1170 | 0.010 |
Why?
|
| Aged | 3 | 2001 | 19424 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 1999 | 198 | 0.010 |
Why?
|
| Logistic Models | 1 | 2000 | 1216 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1999 | 1806 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 2019 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2019 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2001 | 8379 | 0.000 |
Why?
|
| Adolescent | 1 | 2000 | 9354 | 0.000 |
Why?
|